We analyzed the prognosis of abnormal expression of metabolism-related genes in HER2-positive breast cancer by univariate Cox method, and finally identified five genes significantly related to the survival of HER2-positive breast cancer patients, but it is worth noting that these five genes are not related to the survival of triple-negative breast cancer patients. This evidence concerns the gene ERBB2 and breast carcinoma.